We’d love to hear your feedback on this activity. It helps us to continually improve our products.
“It is difficult to evaluate what did not happen.” – Academician, LV Gromashevsky The COVID-19 pandemic may be considered the first global health catastrophe in the past 100 years, since it has affected not only economic, political and medical paradigms, but also our way of life. The rate and distribution of the SARS-CoV-2 virus, despite […]
Video produced by and shared with kind authorisation of the European Academy of Neurology (EAN). On World Brain Day 2020, Professor Günther Deuschl, EAN Past President, gets interviewed by Professor Elena Moro, EAN Secretary General, about research and treatment on Parkinson’s disease.
Video produced by and shared with kind authorisation of the European Academy of Neurology (EAN). On this World Brain Day, the European Federation of Neurological Associations (EFNA) president Joke Jaarsma is interviewing two patients with Parkinson’s disease (PD) on their views to improve clinical care in PD. Veerle Aertsen, vice-president of RaDiOrg, the Belgian Rare Diseases Organisation, […]
Video produced by and shared with kind authorisation of the European Academy of Neurology (EAN). This World Brain Day, Professor Günther Deuschl, EAN Past President is talking to Professor Claudia Trenkwalder, President of the International Parkinson Disease and Movement Disorders Society about the burden of Parkinson´s Disease.
TouchNEUROLOGY caught up with Roger McIntyre (University Toronto, Ontario, Canada) to discuss psychedelics, and in particular psilocybin-based therapies, and their potential in the treatment of mood disorders. Questions 1. Please could you give us a brief overview of psilocybin and its action on serotonergic (5-HT) pathways? (0:04) 2. Which conditions are most likely to benefit […]
Sean Pittock (Mayo Clinic College of Medicine, Rochester, MN, USA) shared with us his expert insights from the phase 3 PREVENT study, a randomized controlled trial of eculizumab in AQP4 antibody-positive participants with neuromyelitis optica (ClinicalTrials.gov Identifier: NCT01892345), including a sub analysis he presented on eculizumab monotherapy. Questions 1. Could you give us an overview […]
Always a pleasure to catch-up with Editorial Board member, Bengt Winblad (Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden), who chatted with us on several topics including his perspective on the COVID-19 pandemic as a Swedish geriatric neurologist. Question What are your thoughts on the COVID-19 pandemic as a Swedish geriatric neurologist? (0:05) Also see […]
I work in a semi-rural practice in South-West Scotland, in one of three practices based in a purpose-built medical centre. As with most NHS general practices we are furnished with relatively outdated computer hardware and old software. Our practice, however, does have the luxury of double monitors allowing access to our EMIS patient data on […]
Delighted to interview our valued Editorial Board member Peter Goadsby (King’s College Hospital, London, UK), who shared his expert insights on visual snow syndrome and related updates presented at the 1st Virtual EAN Congress. Questions 1. What are the clinical features and spectrum of severity of visual snow syndrome, and how was it first identified? […]
Get the latest clinical insights from touchNEUROLOGY